ABOUT (+)-JQ-1 MECHANISM OF ACTION

Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is out there as monotherapy in the two subcutaneous and oral dosage variety (to start with accepted oral GLP-1 receptor agonist). It's been permitted for a second line remedy option for better glycaemic Command in form 2 diabetes and at present beneath scrutiny for anti-obesity goal.